Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma

Journal of Endocrinological Investigation

Volumn 35, Issue 8, 2012, Pages 760-765

  Jaracz, J ^a   Kucharska, A ^a   Rajewska Rager, A ^a   Lacka K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE;

ABLATION THERAPY; ARTICLE; ATTENTION; BECK DEPRESSION INVENTORY; CANCER HORMONE THERAPY; CHRONIC THYROTROPIN SUPPRESSIVE THERAPY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DIFFERENTIATED THYROID CANCER; EXECUTIVE FUNCTION; HAMILTON SCALE; HUMAN; MOOD; ORAL WORD ASSOCIATION TEST; PSYCHOLOGIC TEST; PSYCHOMETRY; RADIOIODINE ABLATIVE THERAPY; STROOP COLOR WORD INTERFERENCE TEST AND DIGIT SPAN; SUBCLINICAL HYPERTHYROIDISM; THYROIDECTOMY; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

ADENOCARCINOMA; ADULT; CELL DIFFERENTIATION; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 84869204322     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8013     Document Type: Article

References (50)

1. Smith JW, Evans T, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002, 26: 45-60. (Pubitemid 34130533)
2. Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves' disease. Gen Hosp Psychiatry 1988, 10: 49-55. (Pubitemid 18043784)
3. Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange AJ Jr. A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996, 8: 181-5. (Pubitemid 26138925)
4. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998, 158: 1413-8. (Pubitemid 28317756)
5. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 2006, 37: 133-9. (Pubitemid 41727903)
6. Baldini IM, Vita A, Mauri MC, at al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21: 925-35. (Pubitemid 27410385)
7. Davis JD, Stern RA, Flashman LA. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr Psychiatry Rep 2003, 5: 384-90. (Pubitemid 38899232)
8. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92: 2545-51. (Pubitemid 47037356)
9. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007, 32: 49-65.
10. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr 2006, 6: 12.
11. Schlote B, Schaaf L, Schmidt R, at al. Mental and physical state in subclinical hyperthyroidism: investigations in a normal working population. Biol Psychiatry 1992, 32: 48-56.
12. Roberts LM, Pattison H, Roalfe A, at al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 2006, 145: 573-81. (Pubitemid 46780936)
13. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS. Health status, mood and cognition in experimentally-induced subclinical thyrotoxicosis. J Clin Endocrinol Metab 2008, 19: 1730-6. (Pubitemid 351656511)
14. Engum A, Bjøro T, Mykletun A, Dahl AA. An association between depression, anxiety and thyroid function - a clinical fact or an artefact? Acta Psychiatr Scand 2002, 106: 27-34. (Pubitemid 34828145)
15. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J of Endocrinol 2006, 154: 787-803. (Pubitemid 43997716)
16. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options Eur J Endocrinol 2005, 152: 1-9. (Pubitemid 40185448)
17. Botella-Carretero JI, Galán JM, Caballero C, Sancho J, Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 2003, 10: 601-10. (Pubitemid 38094894)
18. Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005, 57: 1377-84. (Pubitemid 40798558)
19. Fuster JM. Executive frontal functions. Exp Brain Res 2000, 133: 66-70. (Pubitemid 30411658)
20. Vogel A, Elberling TV, Hørding M, at al. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology 2007, 32: 36-43. (Pubitemid 46001518)
21. Wekking EM, Appelhof BC, Fliers E, at al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 2005, 153: 747-53. (Pubitemid 43020224)
22. Austin MP, Ross M, Murray C, O'Carroll RE, Ebmeier KP, Goodwin GM. Cognitive function in major depression. J Affect Disord 1992, 25: 21-9.
23. Degl'Innocenti A, Agren H, Bäckman L. Executive deficits in major depression. Acta Psychiatr Scand 1998, 97: 182-8.
24. Borkowska A, Rybakowski JK. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord 2001, 3: 88-94. (Pubitemid 32492596)
25. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976, 12: 313-24. (Pubitemid 8008480)
26. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting Test Manual. Revised and Expanded. Odessa, Florida: Psychological Assessment Resources, 1993.
27. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958, 8: 271-6.
28. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935, 18: 643-62.
29. World Health Organization. Geneva: SCAN: Schedule for Clinical Assessment in Neuropsychiatry. Geneva: World Health Organization, 1994.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23: 56-62.
31. Beck AT, Ward CH, Mendelson M, Mock J, Erbaught J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4: 561-71.
32. Khushu S, Kumaran SS, Sekhri T, Tripathi RP, Jain PC, Jain V. Cortical activation during finger tapping in thyroid dysfunction: a functional magnetic resonance imaging study. J Biosci 2006, 31: 543-50. (Pubitemid 46021158)
33. Zhu DF, Wang ZX, Zhang DR, et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 2006, 129: 2923-30.
34. Münte TF, Radamm C, Johannes S, Brabant G. Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: a double-blind cross-over study using event-related brain potentials. Thyroid 2001, 11: 385-91. (Pubitemid 32422633)
35. Whybrow PC, Prange AJ Jr. A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry 1981, 38: 106-13. (Pubitemid 11156719)
36. Dratman MB, Gordon JT. Thyroid hormones as neurotransmitters. Thyroid 1996, 6: 639-47. (Pubitemid 126618482)
37. Bauer M, Whybrow PC. Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatry 2001, 2: 59-69.
38. Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 2002, 7: 140-56. (Pubitemid 34177782)
39. Sulser F. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders. J Clin Psychiatry 1987, 48 (Suppl): 12-8.
40. Frazer A. Norepinephrine involvement in antidepressant action. J. Clin. Psychiatry 2000, 61 (Suppl 10): 25-30. (Pubitemid 30485422)
41. Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 2008, 69 (Suppl E1): 4-7.
42. Gordon JT, Kaminski DM, Rozanov CB, Dratman MB. Evidence that 3,3′,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport. Neuroscience 1999, 3: 943-54. (Pubitemid 29341641)
43. Venditti P, Pamplona R, Ayala V, De Rosa R, Caldarone G, Di Meo S. Differential effects of experimental and cold-induced hyperthyroidism on factors inducing rat liver oxidative damage. J Exp Biol 2006, 209: 817-25.
44. Pasquini JM, Adamo AM. Thyroid hormones and the central nervous system. Dev Neurosci 1994, 16: 1-8. (Pubitemid 24330182)
45. Kalmijn S, Mehta KM, Pols HAP, Hofman A, Drexhage HA, Breteler MMB. Subclinical hyperthyroidism and the risk of dementia, The Rotterdam study Clin Endocrinol (Oxf) 2000, 53: 733-7. (Pubitemid 32096685)
46. de Jong FJ, den Heijer T, Visser TJ at al. Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 2006, 91: 2569-73.
47. Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 2008, 33: 1013-22.
48. Wahlin A, Wahlin TB, Small BJ, Bäckman L. Influences of thyroid stimulating hormone on cognitive functioning in very old age. J Gerontol Psych Sci 1998, 53: P234-9.
49. Wahlin A, Bunce D, Wahlin TB. Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology 2005, 30: 625-37. (Pubitemid 40602357)
50. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76-131. (Pubitemid 351252748)